Laurus Labs Limited logo

Laurus Labs Limited

NSE:LAURUSLABS.NS

Overview | Financials
Company Name Laurus Labs Limited
Symbol LAURUSLABS.NS
Currency INR
Price 499.35
Market Cap 269,229,046,650
Dividend Yield 0.27%
52-week-range 360.85 - 518
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Satyanarayana Chava M.Sc., Ph.D.
Website https://www.lauruslabs.com

An error occurred while fetching data.

About Laurus Labs Limited

Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic

Related Stocks

Aurobindo Pharma Limited logo

Aurobindo Pharma Limited

AUROPHARMA.NS

1,327.55 INR

Lupin Limited logo

Lupin Limited

LUPIN.NS

2,104.6 INR

GlaxoSmithKline Pharmaceuticals Limited logo

GlaxoSmithKline Pharmaceuticals Limited

GLAXO.NS

2,561.15 INR

Max Healthcare Institute Limited logo

Max Healthcare Institute Limited

MAXHEALTH.NS

1,079.25 INR

Alkem Laboratories Limited logo

Alkem Laboratories Limited

ALKEM.NS

5,706.5 INR

Ipca Laboratories Limited logo

Ipca Laboratories Limited

IPCALAB.NS

1,558.65 INR

Zydus Lifesciences Limited logo

Zydus Lifesciences Limited

ZYDUSLIFE.NS

970.35 INR

Abbott India Limited logo

Abbott India Limited

ABBOTINDIA.NS

28,553.1 INR

Syngene International Limited logo

Syngene International Limited

SYNGENE.NS

898.45 INR

Pfizer Limited logo

Pfizer Limited

PFIZER.NS

5,286.85 INR

Financials

Numbers are in millions USD

Numbers are in millions USD